BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REMEDi4ALL
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221114
DTEND;VALUE=DATE:20221116
DTSTAMP:20260423T010637
CREATED:20220819T095738Z
LAST-MODIFIED:20220819T095738Z
UID:235-1668384000-1668556799@remedi4all.org
SUMMARY:Drug Repositioning and Repurposing Conference
DESCRIPTION:Join us at the 10TH ANNUAL DRUG REPOSITIONING AND REPURPOSING CONFERENCE\, where attendees will meet and learn from the world’s foremost experts in the fields of repositioning and repurposing. As the Single Longest-Running Conference in the Space\, Arrowhead Publishers’ annual event continues to be the “go to” meeting for pharma executives\, academicians\, researchers and patient advocacy groups who want to keep abreast of new developments in the field\, learn from experts and meet possible collaborators and partners. \nKey Subjects Covered at This Event\nPatient Advocacy Efforts\nEmphasis on and engagement with patient advocacy groups\, who are investing in drug repositioning efforts to an unprecedented degree. \nNew Partnerships\nThe conference will explore how new partnerships between various groups\, including government\, industry and academia are advancing repurposing. \nSystematic Repositioning & Data Analytics\nRepurposing is no longer based on serendipity as more and more companies are designing tools to streamline and increase the odds of success. \nCutting-Edge Technologies\nArtificial intelligence and other technologies are quickly reshaping drug discovery and development. This event will showcase how they are reshaping the field of drug repurposing. \nRegulatory and Legal Guidance\nLegal\, IP and regulatory guidance will be shared with the audience\, including knowlege and insight into the 505(b)(2) regulatory pathway. \nKey Therapeutic Areas for Repurposing\nRepurposing is beginning to make its mark in a range of therapeutic areas in need of new therapies. Rare and orphan diseases\, tropical diseases and cancer will be discussed in terms of repurposing efforts currently underway.
URL:https://remedi4all.org/event/drug-repositioning-and-repurposing-conference/
LOCATION:Westin Arlington Gateway\, 801 North Glebe Road\, Arlington\, VA\, 22203\, United States
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/08/header2021-drug-repurpose-1.jpg
ORGANIZER;CN="Arrowhead Publishers":MAILTO:enquiries@arrowheadpublishers.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20221019T120000
DTEND;TZID=Europe/Amsterdam:20221020T123000
DTSTAMP:20260423T010637
CREATED:20221020T075537Z
LAST-MODIFIED:20221020T152437Z
UID:568-1666180800-1666269000@remedi4all.org
SUMMARY:Advanced Course in Network Medicine
DESCRIPTION:KI NMA is proud to invite you to participate in an advanced course in Network medicine – “From byte to bench to bed side – addressing large and complex data sets in biomedicine”. \n\nThe advanced course in network medicine “From byte to bench to bed side – addressing large and complex data sets in biomedicine” will be held both at Neo (Campus Flemingsberg) and streamed online.\n\n\nThe course is aimed towards PhD students\, postdocs\, researchers and everyone else that wants to learn more about the topic of network medicine\, its application and implementation. \nThe course will start with a key note speaker\, Professor Ed Silverman\, Channing Division of Network Medicine\, Brigham and Wome’s Hopital/Harvard Medical School\, and the following session of the course will see lecture given by distinguished scientist from Europe and Sweden. The sessions will be followed by panel debates on the pros and cons\, and the innovative potential of Network Medicine. \nUpdated program. Registration is now closed. \n\n 
URL:https://remedi4all.org/event/advanced-course-in-network-medicine/
LOCATION:Campus Flemingsberg & Online
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/10/52955-landscape-full-width-2x.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221010T090000
DTEND;TZID=Europe/London:20221010T180000
DTSTAMP:20260423T010637
CREATED:20220824T081813Z
LAST-MODIFIED:20220824T081813Z
UID:277-1665392400-1665424800@remedi4all.org
SUMMARY:Drug Repurposing for Rare Diseases 2022
DESCRIPTION:We are delighted to announce our ninth annual Drug Repurposing for Rare Diseases Conference and\, for the first time since 2020\, it’s returning live and in-person! \nOur annual conference\, Drug Repurposing for Rare Diseases\, highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments. \nAn event unique in its collaborative and multi-stakeholder focus\, we bring patient groups\, researchers and industry professionals together to showcase excellent examples of rare repurposing. \nDrug Repurposing for Rare Diseases sparks cross-sector conversation\, uniting the expertise of diverse groups to inspire meaningful\, patient-centred drug repurposing research for rare diseases.
URL:https://remedi4all.org/event/drug-repurposing-for-rare-diseases-2022/
LOCATION:America Square Conference Centre\, 17\, One Crosswall\, America Square\, Londen\, EC3N 2LB\, United Kingdom
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2022/08/Maisha.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20220916T000000
DTEND;TZID=Europe/London:20220916T180000
DTSTAMP:20260423T010637
CREATED:20220819T094616Z
LAST-MODIFIED:20220819T094616Z
UID:230-1663286400-1663351200@remedi4all.org
SUMMARY:CeBIL Annual Symposium 2022 - Intellectual Property and Drug Repurposing: New Frontiers
DESCRIPTION:Repurposing\, the idea of finding new treatments for already authorised drugs\, presents significant advantages for drug development. Modern drug development is hindered by high costs and research that takes over a decade. \nRepurposing is a potential solution to these problems because it is cheaper\, faster and safer than developing new compounds. However\, academics\, policymakers and industry experts argue that repurposing is underutilised\, pointing at gaps in patent and pharmaceutical law that make it financially unviable. \nThe symposium will focus on important policy issues for pharmaceutical repurposing. In particular\, it will examine new empirical data on patent protection\, regulatory exclusivities and market authorisation pathways. It will also discuss two new public sector repurposing initiatives launched in the UK and EU\, and investigate other policy frontiers. It will have a hybrid format\, with both in-person and online only tickets available. \nThe 2022 CeBIL Symposium is organised by the Cambridge Centre for Law\, Medicine and Life Sciences (LML) in combination with the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen. The Symposium is generously supported by the Novo Nordisk Foundation. \nHosted by the University of Cambridge\, an international hub for legal and scientific expertise\, we hope the event will stimulate discussion between legal\, economic\,business\, medical\, and scientific experts at a range of career stages. \nConfirmed participants include: \n\nProf. Timo Minssen (CeBIL\, University of Copenhagen)\nProf. Kathleen Liddell (LML\, University of Cambridge)\nProf. Mateo Aboy (LML\, University of Cambridge)\nDr Jakob Wested (CeBIL\, University of Copenhagen & Danish Medicines Agency)\nMs Eugenia Wachters (Healx)\nDr Anita Marguerie de Rotrou (Office for Translational Research\, University of Cambridge)\nMr Adrian Freeman (AstraZeneca)\nProfessor Ken Shadlen (London School of Economics)\nDr John Liddicoat (LML\, University of Cambridge)\nDr Rosemary Lovett (Medicines Repurposing Programme\, NHS England)\nDr Charlotte Asker-Hagelberg (Swedish Medical Products Agency)\nDr Julian Huppert (Intellectual Forum\, Jesus College\, University of Cambridge)\nDr Marco Schito (Critical Path Institute)\nMr Paul Fleming (British Generic Manufacturers Association)\nMs Jacqueline Mulryne (Arnold & Porter)\nProf. Sir Munir Pirmohamed (NHS Chair of Pharmacogenetics & University of Liverpool)\n\nThe CeBIL Symposium will coincide with the EPIP Annual Conference in Cambridge (14-16 September 2022).
URL:https://remedi4all.org/event/cebil-annual-symposium-2022-intellectual-property-and-drug-repurposing-new-frontiers/
LOCATION:Newnham College\, University of Cambridge\, Sidgwick Avenue\, Cambridge\, CB3 9DF\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/08/https-cdn.evbuc_.com-images-286046919-82449972845-1-original.20220517-090934.jpeg
ORGANIZER;CN="Centre for Law%2C Medicine and Life Sciences%2C University of Cambridge":MAILTO:lml@law.cam.ac.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20220902T080000
DTEND;TZID=Europe/Amsterdam:20220903T170000
DTSTAMP:20260423T010637
CREATED:20220818T141600Z
LAST-MODIFIED:20220818T141600Z
UID:224-1662105600-1662224400@remedi4all.org
SUMMARY:REXPO22 – 1st international conference on drug repurposing
DESCRIPTION:The REPO4EU Horizon Europe project to build a European/Global Platform for Drug Repurposing will kick off with the 1st International Conference on Drug Repurposing. \nRExPO22 is the first instalment in the RExPO annual conference series and will take place in Maastricht\, the Netherlands. \nREPO4EU and RExPO22 have partnered with professional societies\, companies\, patent attorneys\, legal and ethics experts\, clinical research organisations\, regulators\, payers\, patient representatives and many more! We have multiple collaborations around the world that pool together their knowledge and know-how to deliver the best possible outcome in the single major opportunity in drug development\, i.e drug repurposing. \nThe speakers include Anton Ussi\, EATRIS Operations and Finance Director\, who will also co-chair the conference. \nFind out more and see the agenda here. Abstract submission is still open here.
URL:https://remedi4all.org/event/rexpo22-1st-international-conference-on-drug-repurposing/
LOCATION:The Function Hall\, Maastricht\, 6229 EP\, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2022/08/https-cdn.evbuc_.com-images-294342909-989138366703-1-original.20220531-085337.jpeg
ORGANIZER;CN="RePo4EU":MAILTO:rexpo@repo4.eu
END:VEVENT
END:VCALENDAR